Frank Genova
Psychiatry · Scottsdale, AZNPI 1396803219
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,426, 4.6 times the $307 reported in 2023.
Across 110 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$451
- Otsuka America Pharmaceutical, Inc.$342
- Johnson & Johnson$326
- Teva Pharmaceuticals USA, Inc.$278
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$158
- Supernus Pharmaceuticals, Inc.$139
- plus $604 from 10 others
What the payments were for
- Food & beverage$2,297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $451 |
| Otsuka America Pharmaceutical, Inc. | 23 | $342 |
| Johnson & Johnson | 10 | $326 |
| Teva Pharmaceuticals USA, Inc. | 11 | $278 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $158 |
| Supernus Pharmaceuticals, Inc. | 2 | $139 |
| Lundbeck LLC | 6 | $134 |
| Corium, LLC | 8 | $120 |
| Alkermes, Inc. | 4 | $84 |
| Ironshore Pharmaceuticals Inc. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Bausch Health US, LLC | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Tris Pharma Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA$128
- VRAYLAR$125
- Austedo XR$117
- QELBREE$116
How this compares
$2,297 in reported general payments places this provider in the 80th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 12 | $184 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Scottsdale
- Henry SchulteScottsdale$77K
- Lauren BonnerScottsdale$44K
- Lois KrahnScottsdale$32K
- Alvin BursteinScottsdale$18K
- Marie GronleyScottsdale$8K
- Alpa SanghviScottsdale$6K
- Adam KoelschScottsdale$5K
- Elizabeth RotellaScottsdale$4K
- Supriya NairScottsdale$4K
- Paul ValbuenaScottsdale$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.